Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Article
in En
| MEDLINE
| ID: mdl-32152073
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Imipenem
/
Drug Resistance, Bacterial
/
Escherichia coli
/
Azabicyclo Compounds
/
Beta-Lactamase Inhibitors
/
Anti-Bacterial Agents
Type of study:
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Year:
2020
Type:
Article